The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 8
- 8 new
- Median first-year cost
- $2,577,583
- $18,572,618 in all
- Institutions
- 8
- 8 contact PIs
- Patents
- 1
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- CLEVELAND CLINIC LERNER COM-CWRU1
- EMORY UNIVERSITY1
- JACKSON LABORATORY1
- MASSACHUSETTS GENERAL HOSPITAL1
- UNIVERSITY OF SOUTH FLORIDA1
and 3 other institutions
Most frequent study sections
- Special Emphasis Panel (ZAG1 ZIJ-6 (A2))8
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2016 | Influence of systemic immune inflammation upon the tauopathy phenotype in mouse models1R01AG051500-01 | Morgan, David | UNIVERSITY OF SOUTH FLORIDA, FL | First-year cost $742,550 | Study section ZAG1 |
| FY2015 | The Neuroimmune System in Alzheimer's Disease1RF1AG051506-01 | El-Khoury, Joseph El | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $3,811,561 | Study section ZAG1 |
| FY2015 | Investigating the Role of Complement-expressing Myeloid Cells in Synapse Loss and Vascular Compromise in Alzheimers Disease1RF1AG051496-01 | Howell, Gareth RStevens, Beth Ann | JACKSON LABORATORY, ME | First-year cost $3,567,446 | Study section ZAG1 |
| FY2015 | Inflammation and Renin-Angiotensin System Dysfunction as risk factors for AD1RF1AG051514-01 | Tansey, Maria De Lourdes GamezWharton, Whitney Lee | EMORY UNIVERSITY, GA | First-year cost $3,352,237 | Study section ZAG1 |
| FY2015 | Amyloid and inflammation: modulation by apoE, gender, air pollution, and drugs1RF1AG051521-01 | Finch, Caleb E | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | First-year cost $3,035,654 | Study section ZAG1 |
| FY2015 | MicroRNA regulation of central nervous system and systemic inflammation in AD1RF1AG051437-01 | Garden, Gwenn AJayadev, Suman | UNIVERSITY OF WASHINGTON, WA | First-year cost $2,119,511 | Study section ZAG1 |
| FY2015 | TREM2 IN MICROGLIA BIOLOGY AND ALZHEIMER'S DISEASE1RF1AG051485-01 | Colonna, Marco | WASHINGTON UNIVERSITY, MO | First-year cost $1,906,250 | Study section ZAG1 |
| FY2015 | Central and Peripheral Roles of TREM2 in Alzheimer's Disease1RF1AG051495-01 | Lamb, Bruce TLandreth, Gary E. | CLEVELAND CLINIC LERNER COM-CWRU, OH | First-year cost $37,409 | Study section ZAG1 |
Patents from its funded projects
1 patent names 1 of the 8 funded projects.
- US 12,226,382 (opens the patent at USPTO, a PDF, in a new tab)METHODS FOR TREATING MICROGLIAL DYSFUNCTIONGranted February 18, 2025 to Washington UniversityRF1AG051485 · WASHINGTON UNIVERSITY, MO
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.